Literature DB >> 17335545

Age dependent systemic exposure to inhaled salbutamol.

Klaus Bønnelykke1, Jakob Jessing Jespersen, Hans Bisgaard.   

Abstract

AIMS: To determine the effect of age on systemic exposure to inhaled salbutamol in children.
METHODS: Fifty-eight asthmatic children, aged 3-16 years, inhaled 400 microg of salbutamol from a pressurized metered dose inhaler with spacer. The 20 min serum profile was analyzed.
RESULTS: Prescribing a dose on a microg kg(-1) basis caused reduced systemic exposure in young children (Y) compared with older children (O) (C(max-microg kg(-1)-adjusted) Y : O ratio (95%CI) = 0.55 (0.47, 0.65)) whereas a fixed nominal dose irrespective of age caused increased exposure in young children (C(max) Y : O ratio (95%CI) = 1.7 (1.3, 2.2)).
CONCLUSIONS: For similar systemic exposure, dosing should be adjusted to age or size but not on a fixed microg kg(-1) basis, which may lead to unnecessary suboptimal dosing.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17335545      PMCID: PMC2000621          DOI: 10.1111/j.1365-2125.2007.02868.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  19 in total

1.  High-percentage lung delivery in children from detergent-treated spacers.

Authors:  J H Wildhaber; H M Janssens; F Piérart; N D Dore; S G Devadason; P N LeSouëf
Journal:  Pediatr Pulmonol       Date:  2000-05

2.  Comparison of the extrapulmonary beta2-adrenoceptor responses and pharmacokinetics of salbutamol given by standard metered dose-inhaler and modified actuator device.

Authors:  D M Newnham; D G McDevitt; B J Lipworth
Journal:  Br J Clin Pharmacol       Date:  1993-11       Impact factor: 4.335

3.  Determination of the relative bioavailability of salbutamol to the lung following inhalation.

Authors:  M Hindle; H Chrystyn
Journal:  Br J Clin Pharmacol       Date:  1992-10       Impact factor: 4.335

Review 4.  Compilation of reference values for lung function measurements in children.

Authors:  P H Quanjer; J Stocks; G Polgar; M Wise; J Karlberg; G Borsboom
Journal:  Eur Respir J Suppl       Date:  1989-03

5.  Inhalation therapy in asthma: nebulizer or pressurized metered-dose inhaler with holding chamber? In vivo comparison of lung deposition in children.

Authors:  J H Wildhaber; N D Dore; J M Wilson; S G Devadason; P N LeSouëf
Journal:  J Pediatr       Date:  1999-07       Impact factor: 4.406

6.  Nebuliser performance, pharmacokinetics, airways and systemic effects of salbutamol given via a novel nebuliser delivery system ("Ventstream").

Authors:  D M Newnham; B J Lipworth
Journal:  Thorax       Date:  1994-08       Impact factor: 9.139

7.  Lung deposition of inhaled drugs increases with age.

Authors:  J Onhøj; L Thorsson; H Bisgaard
Journal:  Am J Respir Crit Care Med       Date:  2000-11       Impact factor: 21.405

8.  The influence of age on aerosol deposition in children with cystic fibrosis.

Authors:  H L Chua; G G Collis; A M Newbury; K Chan; G D Bower; P D Sly; P N Le Souef
Journal:  Eur Respir J       Date:  1994-12       Impact factor: 16.671

Review 9.  Risks versus benefits of inhaled beta 2-agonists in the management of asthma.

Authors:  B J Lipworth
Journal:  Drug Saf       Date:  1992 Jan-Feb       Impact factor: 5.606

10.  Sex differences in hypokalaemic and electrocardiographic effects of inhaled terbutaline.

Authors:  A R Rahman; D G McDevitt; A D Struthers; B J Lipworth
Journal:  Thorax       Date:  1992-12       Impact factor: 9.139

View more
  3 in total

1.  Early bioavailability of inhaled salbutamol reflects lung dose in children.

Authors:  Klaus Bønnelykke; Jacob J Jespersen; Hans Bisgaard
Journal:  Br J Clin Pharmacol       Date:  2008-04-10       Impact factor: 4.335

2.  In Vitro Determination of Respimat® Dose Delivery in Children: An Evaluation Based on Inhalation Flow Profiles and Mouth-Throat Models.

Authors:  Deborah Bickmann; Wolfgang Kamin; Ashish Sharma; Herbert Wachtel; Petra Moroni-Zentgraf; Stefan Zielen
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2015-06-22       Impact factor: 2.849

3.  Plasma concentrations of salbutamol in the treatment of acute asthma in a pediatric emergency. Could age be a parameter of influence?

Authors:  Eloni T Rotta; Sérgio L Amantéa; Pedro E Froehlich; Adriana Becker
Journal:  Eur J Clin Pharmacol       Date:  2010-02-27       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.